NDAORALTABLET
Approved
May 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
MINASTRIN 24 FE (ethinyl estradiol; norethindrone acetate) by Dr. Reddy's Laboratories. Approved for pregnancy. First approved in 2013.
Drug data last refreshed 6h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINASTRIN 24 FE is an oral combined hormonal contraceptive tablet containing ethinyl estradiol and norethindrone acetate, indicated for prevention of pregnancy. It is a small-molecule estrogen/progestin formulation that works by suppressing ovulation and altering cervical mucus to prevent fertilization. The product features a 24-day active hormone phase followed by 4 iron-supplemented placebo tablets.
$0.029BPart D
PeakProduct is at peak revenue stage with modest Part D spending; expect stable commercial teams focused on market maintenance rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
Working on MINASTRIN 24 FE offers stability in a mature contraceptive market but limited growth trajectory given peak lifecycle stage and generic competition. Career development will emphasize defensive market strategy, managed care negotiation, and customer relationship management rather than launch excitement or clinical expansion.
Brand Manager
Worked on MINASTRIN 24 FE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.